Listen to music while browsing

Johnson & Johnson fined $1.1bn in latest Risperdal case

By BBC

Drugs giant Johnson & Johnson (J&J) has been ordered by a US judge to pay $1.1bn (£690m) for downplaying the risks involved in taking its anti-psychotic drug Risperdal.

The state of Arkansas sued J&J and its subsidiary Janssen Pharmaceuticals over its marketing of the drug in 2007.

A number of US states have already found the firms guilty of similar charges and fined them accordingly.

Janssen said it was "disappointed" with the judge's decision.

The company added that if its motion for a retrial was denied, it would appeal the fine.

"During the nearly three-week trial, Janssen presented abundant evidence showing the company acted responsibly and fully complied with all laws and regulations regarding Risperdal," it said in a written statement.

Appeal
In January, J&J agreed to pay $158m to settle allegations of illegal marketing of Risperdal in Texas.

Last year, a South Carolina judge ruled the company must pay a $327m penalty after a jury found it guilty of similar charges, while in 2010, a Louisiana jury found the company violated the state's Medicaid fraud act.

These two verdicts are currently under appeal.
Medicaid is a government-backed US public heath programme for low-income citizens.

a man who wakes up and become rich,did not sleep at night.
By: ailemen caroline omo

IMF: Ghana could be HIPC by end of

Friday, April 17, 2015

According to the International Monetary Fund (IMF), Ghana's total public debt co ...
read more »

Maritime dispute: International Tri

Saturday, April 25, 2015

The International Tribunal for the Law of the Sea has ruled that Ghana cannot dr ...
read more »

Insurance companies introduce sub-r

Wednesday, April 15, 2015

Drivers who commute across the ECOWAS Sub-region would not be required to re-ins ...
read more »

Dumsor crisis: Over 12,000 workers

Wednesday, April 15, 2015

More than 12,000 people have lost their jobs between January and April 2015 alon ...
read more »